JP2025500874A5 - - Google Patents
Info
- Publication number
- JP2025500874A5 JP2025500874A5 JP2024535713A JP2024535713A JP2025500874A5 JP 2025500874 A5 JP2025500874 A5 JP 2025500874A5 JP 2024535713 A JP2024535713 A JP 2024535713A JP 2024535713 A JP2024535713 A JP 2024535713A JP 2025500874 A5 JP2025500874 A5 JP 2025500874A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- expression construct
- peptide
- gastrointestinal peptide
- gastrointestinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163361399P | 2021-12-15 | 2021-12-15 | |
| US63/361,399 | 2021-12-15 | ||
| PCT/IB2022/000815 WO2023131811A2 (en) | 2021-12-15 | 2022-12-15 | Polycistronic expression of gut peptides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025500874A JP2025500874A (ja) | 2025-01-15 |
| JP2025500874A5 true JP2025500874A5 (enExample) | 2025-12-22 |
Family
ID=86732042
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024535713A Pending JP2025500874A (ja) | 2021-12-15 | 2022-12-15 | 消化管ペプチドのポリシストロニック発現 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250302992A1 (enExample) |
| EP (1) | EP4448555A2 (enExample) |
| JP (1) | JP2025500874A (enExample) |
| KR (1) | KR20240133712A (enExample) |
| CN (1) | CN118434758A (enExample) |
| AU (1) | AU2022431978B2 (enExample) |
| CA (1) | CA3239128A1 (enExample) |
| IL (1) | IL313462A (enExample) |
| MX (1) | MX2024007519A (enExample) |
| WO (1) | WO2023131811A2 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026092369A1 (zh) * | 2024-10-31 | 2026-05-07 | 派格生物医药(杭州)股份有限公司 | 一种环状rna分子及其应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ511037A (en) | 1998-09-17 | 2005-02-25 | Univ Florida | Methods for treatment of degenerative retinal diseases |
| AU2002327430A1 (en) * | 2001-08-08 | 2003-02-24 | Genzyme Corporation | Methods for treating diabetes and other blood sugar disorders |
| ATE514776T1 (de) * | 2004-10-05 | 2011-07-15 | California Inst Of Techn | Aptamer-regulierte nukleinsäuren und verwendungen davon |
| US7829664B2 (en) * | 2007-06-01 | 2010-11-09 | Boehringer Ingelheim International Gmbh | Modified nucleotide sequence encoding glucagon-like peptide-1 (GLP-1), nucleic acid construct comprising same for production of glucagon-like peptide-1 (GLP-1), human cells comprising said construct and insulin-producing constructs, and methods of use thereof |
| EA037120B1 (ru) | 2015-02-02 | 2021-02-09 | МЕИРЭДжТиЭкс ЮКей II ЛИМИТЕД | Регулирование экспрессии генов посредством аптамер-опосредованного модулирования альтернативного сплайсинга |
| MX2018009370A (es) | 2016-02-02 | 2018-11-12 | Meiragtx Uk Ii Ltd | Regulacion de expresion genica a través de poliadenilacion modulada por aptámeros. |
| SG11201806589UA (en) | 2016-02-02 | 2018-09-27 | Meiragtx Uk Ii Ltd | Regulation of gene expression via aptamer-mediated control of self-cleaving ribozymes |
| US11311633B2 (en) * | 2016-04-16 | 2022-04-26 | University Of Florida Research Foundation, Incorporated | Satiation peptides for weight loss and altered taste sensitivity |
| MA44546B1 (fr) | 2016-06-15 | 2021-03-31 | Univ California | Virus adéno-associés variants et procédés d'utilisation |
| WO2018156658A1 (en) | 2017-02-21 | 2018-08-30 | MEIRAGTX, UK II Limited | Regulation of gene expression by aptamer-mediated accessibility of polyadenylation signals |
| US11739333B2 (en) | 2017-03-02 | 2023-08-29 | Meiragtx Uk Ii Limited | Regulation of gene expression by aptamer-modulated RNase p cleavage |
-
2022
- 2022-12-15 EP EP22902506.9A patent/EP4448555A2/en active Pending
- 2022-12-15 IL IL313462A patent/IL313462A/en unknown
- 2022-12-15 CN CN202280082853.7A patent/CN118434758A/zh active Pending
- 2022-12-15 KR KR1020247023274A patent/KR20240133712A/ko active Pending
- 2022-12-15 US US18/719,541 patent/US20250302992A1/en active Pending
- 2022-12-15 JP JP2024535713A patent/JP2025500874A/ja active Pending
- 2022-12-15 AU AU2022431978A patent/AU2022431978B2/en active Active
- 2022-12-15 CA CA3239128A patent/CA3239128A1/en active Pending
- 2022-12-15 MX MX2024007519A patent/MX2024007519A/es unknown
- 2022-12-15 WO PCT/IB2022/000815 patent/WO2023131811A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7830441B2 (ja) | Ｇｌｐ－１／ｇｉｐ二重アゴニスト | |
| JP2507106B2 (ja) | インスリン様成長因子１（ｉｇｆ―１）または因子２（ｉｇｆ―２）の類縁ペプチド | |
| KR20110049797A (ko) | 장기 작용성 인터페론 및 그의 유도체 및 그 방법 | |
| CN104302772A (zh) | 用于糖尿病治疗的蛋白、蛋白缀合物及其应用 | |
| JP2010516758A5 (enExample) | ||
| CA2627200A1 (en) | Novel activin receptor and its uses in treating metabolic disorders | |
| JP2022502077A5 (enExample) | ||
| RU2012109553A (ru) | Модифицированные вазоактивные интестинальные пептиды | |
| JP2014519852A5 (enExample) | ||
| CN111566123A (zh) | 胰高血糖素样肽的制备方法 | |
| EA011653B1 (ru) | Аналоги и гибридные полипептиды gip с избираемыми свойствами | |
| JP2013501038A5 (enExample) | ||
| EP0929576A1 (en) | Glp-2 derivatives | |
| JP2020519292A5 (enExample) | ||
| EA007154B1 (ru) | Слитый белок из числа регуляторных/вспомогательных белков вич | |
| AU2008334783A1 (en) | Insulinotropic peptide synthesis using solid and solution phase combination techniques | |
| WO2018011803A1 (en) | Fusion proteins with extended serum half life | |
| JP2025504625A5 (enExample) | ||
| JP2024539139A5 (enExample) | ||
| CN113748125A (zh) | 胰高血糖素样肽-1(glp-1)受体激动剂及其类似物的制备方法 | |
| JP2023548945A5 (enExample) | ||
| JP2024069465A5 (enExample) | ||
| WO2012048653A1 (zh) | 干扰素-白蛋白结合肽的融合蛋白及其用途 | |
| MX2011002885A (es) | Proceso para la sintesis de (aib8,35)hglp-1(7-36)-nh2. | |
| AU2021304762A1 (en) | Novel polypeptide and therapeutic use thereof |